Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Crispr Therapeutics Ag (CRSP)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 516,066 $14,744 +53% 1.73%
2.
Valiant Capital

Christopher R. Hansen

271,700 $7,762 0.73%
3.
EcoR1 Capital

Oleg Nodelman

208,850 $5,967 -59% 0.59%
4. 172,000 $4,914 0.37%
5.
Farallon Capital

Thomas Steyer

1,250,000 $35,713 +23% 0.29%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$24.95 27,461 Large Shareholder 5,380,940 2018-12-27 Filing
$24.89 12,737 Large Shareholder 5,353,479 2018-12-26 Filing
$24.97 53,655 Large Shareholder 5,340,742 2018-12-24 Filing
$23.18 11,742 Large Shareholder 5,287,087 2018-12-24 Filing
$22.91 2,603 Large Shareholder 5,275,345 2018-12-24 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$42.03 3,500 Officer, Director 948,007 2019-03-04 Filing
$41.29 8,912 Officer, Director 951,507 2019-03-04 Filing
$40.24 64,115 Officer, Director 960,419 2019-03-04 Filing
$40.01 8,693 Officer, Director 1,024,534 2019-03-01 Filing
$40.00 14,780 Officer, Director 1,033,227 2019-02-25 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 3,608,874 $103,105,530 51.03%
2. 1,171,268 $33,463 30.4%
3. 444,708 $12,705 3.48%
4. 2,090,678 $59,731 2.36%
5. 1,325,110 $37,858 1.53%